Overview
Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
Status:
Recruiting
Recruiting
Trial end date:
2021-12-01
2021-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Peking Union Medical College Hospital
Criteria
Inclusion Criteria:- adults greater than 18 years-old;
- autoimmune pancreatitis and/or IgG4-related sclerosing cholangitis;
- obstructive jaundice
Exclusion Criteria:
- malignancies; active infections;
- pregnancy or breast feeding;
- standard contraindications to ERCP;
- unwillingness or inability to consent for the study